Malcolm G Witter insider trades: Navidea Biopharmaceuticals (NAVB) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Malcolm reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 17, 2021 | NAVB | ↑ Buy | 20,000 | $1.60 | $32K | Direct | Sep 17, 2021 (0d) |
| Jul 26, 2021 | NAVB | ↑ Buy | 15,000 | $1.70 | $25K | Direct | Jul 26, 2021 (0d) |
| Apr 23, 2021 | NAVB | ↑ Buy | 10,000 | $1.60 | $16K | Direct | Apr 26, 2021 (3d) |
| Mar 29, 2021 | NAVB | ↑ Buy | 21,500 | $2.07 | $45K | Direct | Mar 29, 2021 (0d) |
| Mar 3, 2021 | NAVB | ↑ Buy | 15,000 | $2.31 | $35K | Direct | Mar 3, 2021 (0d) |
| Dec 28, 2020 | NAVB | ↑ Buy | 5,000 | $2.07 | $10K | Direct | Dec 30, 2020 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Malcolm G Witter's insider trades
Malcolm G Witter is a director at Navidea Biopharmaceuticals (NAVB). Since Dec 28, 2020, Malcolm has reported 6 open-market purchases worth $163K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (16 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NAVB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.